Cassava Sciences Stock Price

6.51 (10.51%)
Upgrade to Real-Time
Regular Market


52 Week Range


Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Cassava Sciences Inc SAVA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
6.51 10.51% 68.45 13:24:16
Open Price Low Price High Price Close Price Prev Close
62.14 61.90 69.7998 61.94
Bid Price Ask Price Spread News
68.37 68.49 0.12 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
65,174 7,766,310 $ 67.13 $ 521,340,011 - 6.70 - 146.16
Last Trade Time Type Quantity Stock Price Currency
13:24:16 83 $ 68.37 USD


Draw Mode:

Cassava Sciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 2.75B 40.01M 37.92M $ - $ - -0.25 -141.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 5.00%

more financials information »

Cassava Sciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SAVA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week45.8669.799845.6856.2912,964,63922.5949.26%
1 Month52.9369.799839.0152.0710,344,64115.5229.32%
3 Months90.05146.1639.0174.508,490,666-21.60-23.99%
6 Months46.50146.1631.440171.504,926,44821.9547.2%
1 Year10.99146.166.7055.034,913,36357.46522.84%
3 Years1.21146.161.0032.253,660,48867.245,557.02%
5 Years1.21146.161.0032.253,660,48867.245,557.02%

Cassava Sciences Description

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms.

Your Recent History
Cassava Sc..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.